In the dark: the reporting of blinding status in randomized controlled trials - PubMed
- ️Tue Dec 13 2253
In the dark: the reporting of blinding status in randomized controlled trials
Victor M Montori et al. J Clin Epidemiol. 2002 Aug.
Abstract
To determine the quality of reporting of blinding in randomized controlled trials (RCTs), we evaluated 40 consecutive RCTs published in each of five leading journals. We noted whether authors reported the blinding status of participants, health care providers, data collectors, judicial assessors of outcomes, data analysts, and manuscript writers. Explicit reporting of blinding status occurred in <25% of RCTs for all groups. Eighty-three RCTs, reported as double-blind, provided eight combinations of blinded groups. In conclusion, prestigious journals do not currently report blinding status optimally. To do so, journals should abandon the term "double blind" and explicitly report the blinding status of the groups involved in RCTs. Until such reporting occurs, clinicians will be left with uncertainty about the validity of RCTs that guide their clinical practice.
Similar articles
-
Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
Haahr MT, Hróbjartsson A. Haahr MT, et al. Clin Trials. 2006;3(4):360-5. doi: 10.1177/1740774506069153. Clin Trials. 2006. PMID: 17060210 Review.
-
The reporting of blinding in orthodontic randomized controlled trials: where do we stand?
Abdulraheem S, Bondemark L. Abdulraheem S, et al. Eur J Orthod. 2019 Jan 23;41(1):54-58. doi: 10.1093/ejo/cjy021. Eur J Orthod. 2019. PMID: 29697755 Review.
-
Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM, Bhandari M, Guyatt GH. Devereaux PJ, et al. JAMA. 2001 Apr 18;285(15):2000-3. doi: 10.1001/jama.285.15.2000. JAMA. 2001. PMID: 11308438
-
Devereaux PJ, Choi PT, El-Dika S, Bhandari M, Montori VM, Schünemann HJ, Garg AX, Busse JW, Heels-Ansdell D, Ghali WA, Manns BJ, Guyatt GH. Devereaux PJ, et al. J Clin Epidemiol. 2004 Dec;57(12):1232-6. doi: 10.1016/j.jclinepi.2004.03.017. J Clin Epidemiol. 2004. PMID: 15617948
-
Penić A, Begić D, Balajić K, Kowalski M, Marušić A, Puljak L. Penić A, et al. BMJ Open. 2020 Apr 12;10(4):e035168. doi: 10.1136/bmjopen-2019-035168. BMJ Open. 2020. PMID: 32284390 Free PMC article.
Cited by
-
Who knew? The misleading specificity of "double-blind" and what to do about it.
Lang TA, Stroup DF. Lang TA, et al. Trials. 2020 Aug 5;21(1):697. doi: 10.1186/s13063-020-04607-5. Trials. 2020. PMID: 32758278 Free PMC article.
-
Borg Debono V, Zhang S, Ye C, Paul J, Arya A, Hurlburt L, Murthy Y, Thabane L. Borg Debono V, et al. BMC Anesthesiol. 2012 Jul 4;12:13. doi: 10.1186/1471-2253-12-13. BMC Anesthesiol. 2012. PMID: 22762351 Free PMC article.
-
Blindness and bias in a trial of antidepressant medication for chronic tension-type headache.
Holroyd KA, Tkachuk G, O'Donnell F, Cordingley GE. Holroyd KA, et al. Cephalalgia. 2006 Aug;26(8):973-82. doi: 10.1111/j.1468-2982.2006.01139.x. Cephalalgia. 2006. PMID: 16886934 Free PMC article. Clinical Trial.
-
Tieroshyn V, Moroz L, Prishliak O, Shostakovich-Koretska L, Kruglova O, Gordienko L. Tieroshyn V, et al. Sci Rep. 2020 Apr 14;10(1):6344. doi: 10.1038/s41598-020-62386-0. Sci Rep. 2020. PMID: 32286322 Free PMC article. Clinical Trial.
-
Prady SL, Richmond SJ, Morton VM, Macpherson H. Prady SL, et al. PLoS One. 2008 Feb 13;3(2):e1577. doi: 10.1371/journal.pone.0001577. PLoS One. 2008. PMID: 18270568 Free PMC article.